MedPath

The effect of zinc supplementation on semen parameters, serum and seminal zinc levels of oligozoospermic men attending University of Ilorin Teaching Hospital (UITH): A randomized double - blind trial.

Not Applicable
Recruiting
Conditions
Fertility-male
Registration Number
PACTR202304634296590
Lead Sponsor
Sadiya Musa Gwadabe
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Male
Target Recruitment
82
Inclusion Criteria

1. Male partners of infertile couple within the age of 20-59years having regular unprotected intercourse for a year or more.
2. Men with sperm concentration <15million cells/ml on two occasions 4 weeks apart.
3. Male partners with normal descended testes.
4. Patient who consent to participate in the study

Exclusion Criteria

1. Men with the following problems will be exckuded:Aspermia, azoospermia, testicular varicocele, ongoing sexually transmitted disease, chronic illness, serious systemic disease like diabetes, endocrine and metabolic disorders, smoking, alcohol intake and previous groin or scrotal surgery
2. Men that have used zinc within three months of recruitment /other supplements
3. Men on drugs that suppress spermatogenesis such as steroidsand other immunosuppressive drugs
4. Men with immunosuppressive disease like Human Immunodeficiency Virus (HIV) and malignancy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Baseline seminal and serum zinc levels 2. Serum and seminal zinc level after administration of zinc sulphate or placebo. 3. Baseline sperm count 4. Sperm count after administration of zinc sulphate or placebo
Secondary Outcome Measures
NameTimeMethod
1. Semen parameters (Concentration, motility, morphology and volume) after administration of zinc sulphate and placebo. 2. Adverse effects of the Intervention drug reported by the patients.
© Copyright 2025. All Rights Reserved by MedPath